ABMD Financial Facts
Loss from operations: 766KAmortization of intangible assets: 379K
See Full Income Statement
Additional paid-in-capital: 391.43M
Short-term marketable securities: 55.48M
See Full Balance Sheet
Abiomed Inc. (ABMD) Earnings
|
Expand Research on ABMD
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +7.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/3/22 | Q123 | N/A | $1.06 | N/A | N/A | $276.32M | N/A | N/A | N/A | ||
| 4/28/22 |  |
Q422 | $1.16 | $1.09 | +$0.07 | $270M | $267.67M | N/A |  | | Details |
| 2/3/22 | |
Q322 | $1.13 | $0.97 | +$0.16 | $261M | $253.8M | N/A | | | Details |
| 10/28/21 | |
Q222 | $1.03 | $0.97 | +$0.06 | $248.1M | $247.66M | N/A | | | Details |
8/5/21  |
|
Q122 | N/A | $1.05 | N/A | N/A | $240.91M | N/A | N/A | N/A | |
| 4/29/21 | |
Q421 | $1.11 | $1.10 | +$0.01 | $241M | $230.38M | N/A | | | Details |
| 1/28/21 | |
Q321 | $1.35 | $1.13 | +$0.22 | $231.7M | $225.59M | N/A | | | Details |
| 10/29/20 | |
Q221 | $1.36 | $0.92 | +$0.44 | $209.8M | $198.93M | N/A | | | Details |
